These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 604778)

  • 41. Fenfluramine in management of obese diabetics.
    Misra NP; Bhambal SA; Yesikar SS; Bellani RK
    J Assoc Physicians India; 1980 Sep; 28(9):287-95. PubMed ID: 7007309
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

  • 43. Prolonged action fenfluramine in general practice.
    Owen JH
    Br J Clin Pract; 1975 Jan; 29(1):13-14. PubMed ID: 1095043
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of fenfluramine (with ad libitum food intake) with 1,000 calorie diet in obesity.
    Hooper AC
    J Ir Med Assoc; 1972 Jan; 65(2):35-7. PubMed ID: 5058787
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chronotherapy of obesity. I. Effect of fenfluramine on the decrease of adipose mass in the obese, in relation to the time of administration].
    Guagnano MT; Di Vincenzo M; Sensi S
    Boll Soc Ital Biol Sper; 1982 Jun; 58(12):736-9. PubMed ID: 7104096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reducing therapy in obesity].
    Dekant A; Dekant H
    Z Allgemeinmed; 1973 Sep; 49(27):1305-9. PubMed ID: 4757768
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of benfluramate on carbohydrate metabolism in obesity.
    Asmal AC; Leary WP; Deppe W; Lockett CJ
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):95-103. PubMed ID: 905637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fenfluramine-associated hypertension.
    Mabadeje AF
    West Afr J Pharmacol Drug Res; 1975 Dec; 2(2):145-52. PubMed ID: 1233823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Different therapies in the treatment of obesity in hypertensive patients].
    Monego ET; Peixoto Mdo R; Jardim PC; Sousa AL; Braga VL; Moura MF
    Arq Bras Cardiol; 1996 Jun; 66(6):343-7. PubMed ID: 9035450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Regulation of food intake and the treatment of obesity using centrally-active serotonergic drugs].
    Pijl H; Koppeschaar HP; Zelissen PM; Meinders AE
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):700-3. PubMed ID: 2038393
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of fenfluramine and placebo on obese Nigerians.
    Lewis EA; Adeleye GI; Ukponmwan OO
    Niger Med J; 1978; 8(2):104-7. PubMed ID: 347827
    [No Abstract]   [Full Text] [Related]  

  • 52. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
    Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacological effects of 780SE (992) on hyperlipidaemic and obese rats.
    Duhault J; Boulander M; Beregi L
    Postgrad Med J; 1975; 51 Suppl 1():99-104. PubMed ID: 1219688
    [No Abstract]   [Full Text] [Related]  

  • 54. A trial of fenfluramine (PACaps) and diet in overweight diabetic patients.
    Wells HM
    Postgrad Med J; 1975; 51 Suppl 1(593):137. PubMed ID: 1219672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug therapy of obesity--results of treatment with dexfenfluramine].
    Ivković-Lazar T; Stokić E; Lepsanović L
    Med Pregl; 1990; 43(5-6):232-5. PubMed ID: 2287309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects.
    Balasse EO; Couturier E; Kornitzer M; Degre S
    Postgrad Med J; 1975; 51 Suppl 1():157. PubMed ID: 768958
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is fenfluramine a suitable therapeutic principle in obese aged diabetics?].
    Förster H; Huth K; Koch E; Tunali G
    Fortschr Med; 1979 Jan; 97(4):169-74. PubMed ID: 422110
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of obesity with fenfluramine. Clinical experiences and biochemical correlations].
    Guemes Diaz JF
    Vie Med Can Fr; 1973 Mar; 2(3):232-5. PubMed ID: 4707492
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinical trial of fenfluramine in obese children.
    Bacon GE; Lowrey GH
    Curr Ther Res Clin Exp; 1967 Dec; 9(12):626-30. PubMed ID: 4965459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.